Massimo Masiero

Company: Bicycle Therapeutics

Job title: Associate Director, Molecular Pharmacology

Seminars:

Panel Discussion: Curating a Target Selection Strategy With Adequate Risk Management to Maintain Investor Buy-In & Strategic Differentiation 9:30 am

Strategizing how to penetrate the dense ADC field whilst taking adequate risks in relation to target selection or ADC design Understanding the degree of risk deemed acceptable by prospective investors to decide the target of choice Considering scenarios appropriate to advance a novel ADC with a novel task, in a high risk approachRead more

day: Conference Day Two

Concluding the Decision-Making Process When Opting for Established or Novel Targets in Alignment With Your ADC in Question 10:15 am

Proposing how you can leave your mark on the ADC space when utilizing traditional targets as opposed to a novel target approach Concluding the current motivations across the ADC field: To be first-in-class or best-in-class Brainstorming the lessons to be learned from traditional targets which can be applied to a novel target selection strategyRead more

day: Conference Day Two

A Hanson Wade Group Company

© Copyright 2025 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.